|
Real-time Estimate
Tradegate
12:47:01 2026-10-05 EDT
|
5-day change | 1st Jan Change | ||
| 15.80 EUR | +2.25% |
|
+1.22% | +47.20% |
| 09:31am | UBS Adjusts Price Target on Viatris to $26 From $23, Keeps Buy Rating | MT |
| 08:23am | Harrow Completes Acquisition of Tyrvaya Nasal Spray From Viatris | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Viatris Inc.(VTRS)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
Viatris Inc.(VTRS)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
Viatris Inc.(VTRS)
EBIT
Dividend / Share (DPS)
Data source:
Viatris Inc.(VTRS)
Cash or Net Debt
- Stock Market
- Stocks
- VTRS Stock
- VTRS Stock
- Consensus Viatris Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
